Description

Bovine Rhinotracheitis-Virus Diarrhea-Campylobacter fetus-Leptospira canicola-L. grippotyphosa-L. hardjo-L. icterohaemorrhagiae-L. pomona Bacterin. Express FP 3-VL5 contains neomycin as a preservative.

Features

Convenient combination for the breeding herd; three major viral components plus 5-way Lepto and C. fetus (Vibrio)

Express FP family of vaccines is the first vaccine line licensed by the USDA that prevents persistently infected calves caused by BVD Types 1&2

Proven studies show protection against 4 different strains, including BVD Type 1a, 1b and Type 2

Engineered to provide 90-99% protection against persistently infected (PI) calves due to BVD Types 1&2

Proven protection against both cytopathic and non-cytopathic strains of BVD

A controlled study showed 90-99% efficacy in preventing abortions due to BVD Type 2

Separate controlled studies showed the onset of protection against IBR at 3 days(1) and BVD Type 2 at 5 days post-vaccination(2)

BQA compliant 2 mL Sub-Q dose

Benefits

Provides the strongest protection available to the market in a vaccine for the prevention of PI calves due to BVD Types 1&2

The vaccine comes with a BIVI guarantee that covers the cost of a BVD PI calf being born into a herd, thereby removing producer risk (see guarantee for complete details)

Broad coverage for major reproductive and respiratory diseases that affect cattle

Combination reduces number of injection sites and labor

Reduces concern of vaccine virus shedding

Meets the BQA low dose guidelines

Advantages

Express FP 3-VL5 vaccine provides the ultimate in protection against BVD Types 1&2, including removing the risk of PI calves being born into the herd

Dosage & Administration

Using aseptic technique, inject 2 mL subcutaneously in front of the shoulder and midway of the neck, away from the suprascapular lymph node. If initial vaccination, repeat with C. fetus and Leptospira fractions (Citadel‚Ñ¢ VL5) in 14-28 days. Calves vaccinated before 6 months of age should be revaccinated at 6 months or at weaning. A 2 mL booster dose is recommended once annually.
Cows and Heifers: Using aseptic technique, annually inject a single 2 mL dose subcutaneously at or about 4 weeks prior to breeding. If initial vaccination, see above.

Precautions

Store out of direct sunlight at 35-45°F (2-7°C). Avoid freezing. Use entire contents when first opened. Burn container and all unused contents. Do not vaccinate within 21 days of slaughter. Stressed cattle should not be vaccinated. Do not use in pregnant cows or calves nursing pregnant cows. Anaphylactoid reactions may occur. Antidote: Epinephrine

Highlights

- The 1st vaccine licensed with a label claim for prevention of PI calves due to BVD Types 1&2

- Product comes with a BIVI guarantee to remove the risk of a BVD PI calf being born into a herd

- Five studies have shown 90-99% protection against PI calves due to BVD Types 1&2

- Provides convenient and broad reproductive and respiratory protection in one syringe

- Part of the fetal protection family formerly known as Breed-Back® FP

Uses

Express FP 3-VL5 is recommended for the vaccination of healthy cows and replacement heifers prior to breeding to prevent persistently infected calves caused by BVD Types 1&2. For the vaccination of healthy susceptible cattle as an aid in reduction of respiratory disease caused by IBR-BVD Types 1&2, as an aid in the reduction of infertility, delayed conception or abortion caused by Campylobacter fetus and leptospirosis caused by Leptosipira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.

Warning

It is possible that healthy appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. In view of these findings and suggested causes, BVD vaccine is contraindicated in persistently infected cattle and use should be limited to healthy, immunocompetent, unstressed, non-pregnant cattle.

Product Information

Title	Type
Field Safety in Female Cattle Receiving Express FP MLV Vaccine in Combination with Leptospira serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, pomona - campylobacter fetus (Vibrio) bacterin.	Tech Bulletin
Onset of Protection from Direct Challenge of BVD Type 1 Virus following Vaccination with Express 5 Vaccine	Tech Bulletin
Safety of Express MLV vaccines in pregnant cows or calves nursing pregnant cows	Tech Bulletin
EXPRESS® FP VACCINES UNSURPASSED PROTECTION AGAINST BVD PERSISTENT INFECTION	Tech Bulletin
Express vaccines now USDA-approved for use in whole-herd vaccination programs.	News
BOEHRINGER INGELHEIM VETMEDICA, INC., RECEIVES INDUSTRY’S FIRST BVD PI PREVENTION CLAIM FOR VACCINES	News
EXPRESS® FP 3 VL5 OFFERS CONVENIENCE PLUS PREVENTION OF BVD PI CALVES	News

Packaging Options (top)

Contact Information For Express® FP 3-VL5 (top)

Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
800-821-7467 Information
800-325-9167 Sales
816-236-2717
email: judith.sprague@boehringer-ingelheim.com
internet: http://www.bi-vetmedica.com

General Product Information Documents (top)

Product Image for Express® FP 3-VL5 (top)